Letter: proving the benefit of exercise intervention in metabolic associated fatty liver disease - authors' reply

O'Gorman, P, Naimimohasses, S, Monaghan, A et al. (5 more authors) (2020) Letter: proving the benefit of exercise intervention in metabolic associated fatty liver disease - authors' reply. Alimentary Pharmacology and Therapeutics, 52 (8). pp. 1426-1427. ISSN 0269-2813

Abstract

Metadata

Authors/Creators:
Commentary on: O’Gorman, P, Naimimohasses, S, Monaghan, A et al. (9 more authors) (2020) Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention. Alimentary Pharmacology & Therapeutics. ISSN 0269-2813
Copyright, Publisher and Additional Information: © 2020 John Wiley & Sons Ltd. This is the peer reviewed version of the following article: O'Gorman, P, Naimimohasses, S, Monaghan, A et al. (5 more authors) (2020) Letter: proving the benefit of exercise intervention in metabolic associated fatty liver disease - authors' reply. Alimentary Pharmacology and Therapeutics, 52 (8). pp. 1426-1427. ISSN 0269-2813, which has been published in final form at http://doi.org/10.1111/apt.16070. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Dates:
  • Published: October 2020
  • Accepted: 11 August 2020
  • Published (online): 20 September 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Environment (Leeds) > School of Food Science and Nutrition (Leeds) > FSN Nutrition and Public Health (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Sep 2020 11:04
Last Modified: 23 Sep 2020 11:04
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/apt.16070

Commentary/Response Threads

Download

Accepted Version


Embargoed until: 20 September 2021

Filename: O'Gorman et al_Authors reply FINAL DRAFT.pdf

Request a copy

file not available

Share / Export

Statistics